Free Trial

STAAR Surgical (STAA) Competitors

STAAR Surgical logo
$26.66 -0.64 (-2.34%)
(As of 11/15/2024 ET)

STAA vs. EYE, HAE, ICUI, XRAY, NEOG, QDEL, CERS, OSUR, ANIK, and UTMD

Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include National Vision (EYE), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Neogen (NEOG), QuidelOrtho (QDEL), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "medical" sector.

STAAR Surgical vs.

STAAR Surgical (NASDAQ:STAA) and National Vision (NASDAQ:EYE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations.

STAAR Surgical has a net margin of 6.38% compared to National Vision's net margin of -0.81%. STAAR Surgical's return on equity of 6.77% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical6.38% 6.77% 5.39%
National Vision -0.81%3.52%1.39%

STAAR Surgical received 34 more outperform votes than National Vision when rated by MarketBeat users. However, 65.63% of users gave National Vision an outperform vote while only 55.60% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
288
55.60%
Underperform Votes
230
44.40%
National VisionOutperform Votes
254
65.63%
Underperform Votes
133
34.37%

96.7% of STAAR Surgical shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by insiders. Comparatively, 2.3% of National Vision shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

STAAR Surgical has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, National Vision has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500.

In the previous week, STAAR Surgical had 2 more articles in the media than National Vision. MarketBeat recorded 6 mentions for STAAR Surgical and 4 mentions for National Vision. STAAR Surgical's average media sentiment score of 0.99 beat National Vision's score of 0.94 indicating that STAAR Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STAAR Surgical currently has a consensus price target of $43.33, indicating a potential upside of 62.54%. National Vision has a consensus price target of $14.00, indicating a potential upside of 26.93%. Given STAAR Surgical's stronger consensus rating and higher probable upside, equities research analysts clearly believe STAAR Surgical is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
National Vision
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

STAAR Surgical has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$341.22M3.85$21.35M$0.4460.59
National Vision$2.13B0.41-$65.90M-$0.20-55.15

Summary

STAAR Surgical beats National Vision on 14 of the 18 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STAA vs. The Competition

MetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$1.31B$11.34B$5.06B$8.67B
Dividend YieldN/A1.63%5.06%4.06%
P/E Ratio60.5935.3798.9217.12
Price / Sales3.854.741,205.7371.29
Price / Cash38.8617.9840.6936.36
Price / Book3.073.096.325.87
Net Income$21.35M$224.33M$119.47M$225.66M
7 Day Performance-9.90%-3.37%-5.11%-1.34%
1 Month Performance-16.84%-1.48%-3.21%1.00%
1 Year Performance-24.39%15.28%32.41%25.27%

STAAR Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STAA
STAAR Surgical
4.8603 of 5 stars
$26.66
-2.3%
$43.33
+62.5%
-24.4%$1.31B$341.22M60.591,115Short Interest ↓
EYE
National Vision
3.7112 of 5 stars
$11.03
+0.7%
$14.00
+26.9%
-42.3%$868.61M$2.13B-55.1513,998Short Interest ↓
HAE
Haemonetics
4.784 of 5 stars
$89.22
-1.7%
$107.88
+20.9%
+0.0%$4.48B$1.36B37.023,657Analyst Forecast
News Coverage
ICUI
ICU Medical
4.1571 of 5 stars
$167.86
-2.4%
$173.00
+3.1%
+92.7%$4.11B$2.34B-36.7314,000Analyst Downgrade
Short Interest ↓
News Coverage
XRAY
DENTSPLY SIRONA
4.9012 of 5 stars
$18.28
+2.3%
$29.50
+61.4%
-38.2%$3.63B$3.90B-8.8315,000
NEOG
Neogen
2.22 of 5 stars
$14.60
-0.3%
$17.50
+19.9%
-8.5%$3.16B$912.20M-132.732,640
QDEL
QuidelOrtho
4.437 of 5 stars
$36.18
-7.1%
$58.83
+62.6%
-44.8%$2.43B$2.82B-1.307,100Options Volume
CERS
Cerus
2.8499 of 5 stars
$1.72
-4.4%
$3.63
+110.8%
-0.6%$319.43M$176.23M-15.64625Short Interest ↑
OSUR
OraSure Technologies
4.6184 of 5 stars
$3.85
-3.5%
$6.67
+73.2%
-44.2%$287.17M$405.47M25.67638
ANIK
Anika Therapeutics
3.8926 of 5 stars
$17.25
+1.5%
$24.50
+42.0%
-17.6%$252.64M$164.17M-2.59357High Trading Volume
UTMD
Utah Medical Products
3.3408 of 5 stars
$66.05
-0.7%
N/A-22.2%$225.61M$50.22M15.47180Positive News

Related Companies and Tools


This page (NASDAQ:STAA) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners